Support Care Cancer (2018) 26:1323–1334 https://doi.org/10.1007/s00520-017-3959-2 ORIGINAL ARTICLE NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim 1 2 3 4 5 Jeffrey J. Kirshner & Maxwell C. McDonald III & Flavio Kruter & Andrew S. Guinigundo & Linda Vanni & 6 7 7 7,8 7 Cathy L. Maxwell & Maureen Reiner & Terry E. Upchurch & Jacob Garcia & Phuong Khanh Morrow Received: 20 March 2017 /Accepted: 3 November 2017 /Published online: 16 November 2017 The Author(s) 2017. This article is an open access publication Abstract pain. The primary endpoint was all-grade bone pain in Purpose Mild-to-moderate bone pain is a commonly reported cycle 1 from AE reporting. Secondary endpoints included adverse event (AE) associated with pegfilgrastim. We evalu- bone pain in cycles 2–4 and across all cycles from AE ated the effect of prophylactic naproxen or loratadine vs no reporting and patient-reported bone pain by cycle and prophylactic treatment on pegfilgrastim-associated bone pain. across all cycles. Methods In this open-label study (NCT01712009), wom- Results Six hundred patients were enrolled. Most patients en ≥ 18
Supportive Care in Cancer – Springer Journals
Published: Nov 16, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
It’s easy to organize your research with our built-in tools.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud